T-cell engineering involves the modification of T-cells to enhance their ability to recognize and attack cancer cells, thereby offering a promising approach in immunotherapy. This technique harnesses genetic engineering to create chimeric antigen receptor (CAR) T-cells or T-cell receptor (TCR) modified cells, which can target specific tumor antigens with high precision.